FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Syndicate content

GlaxoSmithKline related Press Releases

NICE upholds GSK appeal for advanced breast cancer treatment, Tyverb® (lapatinib)

Posted July 9, 2009

NICE upholds GSK appeal for advanced breast cancer treatment, Tyverb® (lapatinib) - NICE will reconsider the evidence supporting lapatinib The National Institute for Health and Clinical... Read more...

GSK and Chroma Therapeutics form alliance to develop novel macrophage-targeted drugs

Posted June 23, 2009

GSK and Chroma Therapeutics form alliance to develop novel macrophage-targeted drugs GlaxoSmithKline (LSE: GSK) and Chroma Therapeutics Limited, announced today a collaboration todevelop... Read more...

GSK announces a strategic alliance with Dr. Reddy's to further accelerate sales growth in emerging markets

Posted June 15, 2009

GSK announces a strategic alliance with Dr. Reddy's to further accelerate sales growth in emerging markets Issued: Monday 15 June 2009, London UK GlaxoSmithKline plc (GSK) today announced an... Read more...

Orexigen Therapeutics, Inc. Announces In-Licensing of Key Patents from GlaxoSmithKline (GSK)

Posted June 11, 2009

Orexigen Therapeutics, Inc. Announces In-Licensing of Key Patents from GlaxoSmithKline (GSK) to Further Strengthen its Intellectual Property Estate for Contrave SAN DIEGO, June 11... Read more...

Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies

Posted May 18, 2009

Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic AntibodiesOxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel... Read more...

GSK extends strategic collaboration with Aspen

Posted May 12, 2009

GSK extends strategic collaboration with Aspen - GSK to acquire 16% shareholding in Aspen in exchange for transfer of specialist products and manufacturing facility in Bad Oldesloe, Germany -

... Read more...

Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009

Posted May 11, 2009

Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009 Data Include First Presentation of Phase III Progression Free Survival Results for Pazopanib in Kidney

... Read more...

New data for GlaxoSmithKline's vaccine, Cervarix, presented at IPV Conference

Posted May 8, 2009

New data for GlaxoSmithKline's vaccine, Cervarix, presented at IPV Conference Issued: Friday 8 May 2009, London, UK & Malmö, Sweden Key results from three important studies of the cervical

... Read more...

GlaxoSmithKline to divest US rights for Wellbutrin XL® to Biovail for $510 million

Posted May 6, 2009

GlaxoSmithKline to divest US rights for Wellbutrin XL® to Biovail for $510 million Issued: Wednesday 6th May 2009, Research Triangle Park, NC GlaxoSmithKline plc (GSK) today announced that it

... Read more...

Emergence of a new H1N1 influenza A strain (swine influenza)

Posted April 27, 2009

Emergence of a new H1N1 influenza A strain (swine influenza) Issued: Monday 27 April 2009, London UK GlaxoSmithKline (GSK) is closely monitoring the situation regarding the emergence of a new

... Read more...